Dr. Heather Mitchell -- Pharmaceutical Payment Report
This page provides a comprehensive transparency report for Dr. Heather Mitchell, a Cardiology physician based in Springfield, IL. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Heather Mitchell has received $23,598.03 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.
Physician Profile
The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.
- Full Name: Dr. Heather Mitchell
- Medical Specialty: Cardiology
- Practice Location: Springfield, IL, Illinois
- NPI Number: 1927061410
- Transparency Score: 50/100
- Payment Records Span: 2024-06-27 to 2024-06-27
Payment Summary
Dr. Heather Mitchell has received a total of $23,598.03 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $23,598.03 per transaction.
- Total Payments Received: $23,598.03
- Number of Transactions: 1
- Average Payment: $23,598.03
- Transparency Score: 50/100 -- This score reflects the overall payment profile relative to peers in Cardiology. A higher score indicates fewer or more routine payments.
- Number of Pharma Relationships: 1 pharmaceutical companies
Payment Breakdown by Category
The following table shows how Dr. Heather Mitchell's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.
| Payment Category | Amount | Description |
|---|---|---|
| Consulting Fees | $23,598.03 | Advisory board participation, clinical consulting, and expert opinion services |
The largest payment category for Dr. Heather Mitchell is Consulting Fees, accounting for 100% ($23,598.03) of total pharmaceutical payments received. This suggests active involvement in pharmaceutical company advisory and educational programs.
Pharmaceutical Company Relationships
The following pharmaceutical and medical device companies have made payments to Dr. Heather Mitchell. Click on any company name to view their full physician payment profile and spending patterns.
| Company | Total Paid | Transactions |
|---|---|---|
| Pfizer Inc | $23,598.03 | 1 |
Dr. Heather Mitchell has a financial relationship with Pfizer Inc, receiving $23,598.03 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.
AI Transparency Analysis
The following analysis was generated by artificial intelligence based on Dr. Heather Mitchell's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.
Dr. Heather Mitchell, a cardiologist in Springfield, IL, has a pharmaceutical payment profile characterized by a single, substantial payment. With a total of $23,598.03 from pharmaceutical companies, this volume is notably higher than the typical range for cardiologists, though it stems from a single transaction. The data indicates that Pfizer Inc. is the sole pharmaceutical entity with a recorded payment to Dr. Mitchell, amounting to the entire $23,598.03. This payment, received on June 27, 2024, was for consulting services. The singular nature of this payment, specifically for consulting, suggests a focused engagement rather than a broad pattern of financial relationships. While a single large consulting fee can be a legitimate form of professional compensation for expertise, it warrants attention due to its size and the fact that it represents the entirety of Dr. Mitchell's reported pharmaceutical income. It is important for patients to understand that pharmaceutical companies engage with physicians for various reasons, including sharing information about new treatments, gathering insights on drug effectiveness, and funding research. Payments for consulting can involve providing expert opinions on drug development, clinical trial design, or market insights. However, such relationships can create potential conflicts of interest, as they may subtly influence a physician's prescribing habits or their perception of a drug's benefits. Patients should view this information as a piece of the larger puzzle when evaluating their healthcare provider. It does not automatically indicate compromised care but encourages informed discussion and awareness.
Patient Guidance: Questions to Ask Your Doctor
If Dr. Heather Mitchell is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:
When reviewing your doctor's financial relationships with pharmaceutical companies, it's essential to maintain perspective. A single, large payment for consulting, as seen with Dr. Mitchell, is different from a pattern of frequent, smaller payments for meals or speaking. While any financial tie can potentially influence a physician, a one-time consulting fee might reflect a specific project or advisory role. Patients should feel empowered to ask their doctor about these relationships. You can inquire, 'I saw that you received a payment from [Pharma Company] for consulting. Could you tell me more about that engagement and how it relates to your practice?' This opens a dialogue. Red flags might include a doctor who consistently receives payments from companies whose drugs they frequently prescribe, especially if they seem overly enthusiastic about a particular medication without clear clinical justification. Normal professional activity often involves physicians sharing their expertise through speaking or consulting, which can be beneficial for disseminating medical knowledge. However, if payments seem excessive, frequent, or tied to specific drug promotion, it warrants closer scrutiny. Evaluate your doctor's prescribing patterns independently by looking at drug formularies and considering alternative treatments. Transparency data is a tool for informed discussion, not an automatic reason to distrust your physician.
Peer Comparison: How Dr. Heather Mitchell Compares to Other Cardiology Physicians
Cardiologists typically receive a range of payments from pharmaceutical companies, often involving multiple smaller transactions for speaking engagements, meals, and consulting. While the average total payment can vary significantly, a single payment of $23,598.03 for consulting is considerably higher than the average individual transaction and represents the entirety of reported income for Dr. Mitchell. This outlier payment makes direct comparison difficult, but it suggests a more concentrated relationship with a single company compared to the more distributed payment patterns often seen among peers.
Recent Payment Records
The following table shows the most recent pharmaceutical industry payments recorded for Dr. Heather Mitchell in the CMS Open Payments database. Click on any payment to view the full report.
| Company | Amount | Type | Drug/Device | Date | Conflict Level |
|---|---|---|---|---|---|
| Pfizer Inc | $23,598.03 | consulting | N/A | 2024-06-27 | Not Assessed |
Frequently Asked Questions About Dr. Heather Mitchell's Pharma Payments
Below are common questions patients ask about physician pharmaceutical payment data.
Is Dr. Heather Mitchell taking too much pharma money?
Dr. Mitchell has received a single payment of $23,598.03 from Pfizer Inc. for consulting. While this amount is substantial for a single transaction, it represents her entire reported pharmaceutical income. Compared to the broader cardiology field, where payments can be more frequent and varied, this profile is less indicative of a pervasive financial entanglement. However, the size of this single payment warrants patient awareness and the opportunity for discussion with the doctor about the nature of the consulting engagement.
What pharma companies pay Dr. Heather Mitchell?
Dr. Heather Mitchell has received payments exclusively from Pfizer Inc. The total amount paid by Pfizer Inc. is $23,598.03.
Should I switch doctors because of pharma payments?
A single payment, even a substantial one, is not an automatic reason to switch doctors. Consider the context: is it a one-time consulting fee or a pattern of frequent payments? If the payments are infrequent and for legitimate professional activities like consulting or research, it may not be a cause for concern. However, if you observe a pattern of frequent payments from companies whose drugs your doctor prescribes, or if your doctor seems to be promoting specific medications without clear clinical rationale, it might be a reason to seek a second opinion or discuss your concerns further.
What kinds of payments does this doctor receive?
Dr. Mitchell has received one type of payment: consulting. The total amount for consulting is $23,598.03, all from Pfizer Inc. There are no reported payments for speaking, meals, travel, research, or ownership interests.
How do these payments compare to other Cardiology?
The average cardiologist may receive payments from multiple pharmaceutical companies for various services like speaking, meals, and consulting. While payment volumes vary widely, Dr. Mitchell's profile of a single, large consulting payment of $23,598.03 is less typical than the more distributed payment patterns often seen in the specialty. This suggests a more concentrated, albeit singular, relationship with Pfizer Inc.
Do pharma payments affect prescribing quality?
Research suggests that even small payments can influence physician prescribing habits, potentially leading to increased use of the paying company's drugs. While not all payments are problematic, and many represent legitimate professional interactions, a potential for bias exists. Patients should consider this data alongside their doctor's overall clinical judgment, treatment recommendations, and their own research into medication options.
How can I verify this payment data?
You can verify this payment data directly through the Centers for Medicare & Medicaid Services (CMS) Open Payments database. Visit the official CMS Open Payments website and use the search function to look up Dr. Heather Mitchell by her name and NPI (1927061410). The database provides detailed records of payments made by pharmaceutical and medical device companies to physicians and teaching hospitals.
Understanding This Doctor Payment Report
This transparency report for Dr. Heather Mitchell is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:
- Payment does not imply wrongdoing. Many pharmaceutical payments represent legitimate professional activities such as consulting on drug development, speaking at medical education events, and conducting clinical research.
- Context matters. A large payment for conducting a clinical trial has very different implications than a large payment for promotional speaking. The payment breakdown by category above provides this context.
- Peer comparison is important. Whether a payment amount is unusual depends heavily on the physician's specialty, geographic location, and career stage. Cardiology physicians may have very different payment norms than physicians in other fields.
- Data may be incomplete. The CMS Open Payments database captures payments from pharmaceutical and medical device manufacturers. It does not include payments from other sources, such as hospitals, insurance companies, or government agencies.
- Reporting thresholds apply. Small payments below certain thresholds may not be individually reported. The totals reflect payments above reporting minimums set by CMS regulations.
About the Physician Payments Sunshine Act
The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.
Under this law, Dr. Heather Mitchell's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.
The Open Payments data for Dr. Heather Mitchell and all other physicians can be accessed at the official CMS Open Payments website.
Related Resources
- Cardiology Specialty Payment Data -- See payment patterns for all cardiology physicians
- Illinois Physician Payments -- Browse pharmaceutical payments to physicians in Illinois
- Cardiology Physicians in Illinois -- Compare Dr. Heather Mitchell to peers in the same state and specialty
- Pfizer Inc Payment Profile -- View all payments made by Dr. Heather Mitchell's largest pharmaceutical partner
- Search for Another Doctor or Company -- Look up any physician or pharmaceutical company in our database
- Official CMS Open Payments Database -- Verify payment data directly with the federal government
- NPI Registry -- Look up Dr. Heather Mitchell's NPI (1927061410) in the official provider registry
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.